Form 4 Tracker
TAKEDA PHARMACEUTICAL CO LTD
TAK

52 insider filings · Latest: Sep 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Dec 4, 2025Dec 4 11:02 AMGiles Richard Platford
Proposed Sale
58,421$14.31$836.0K—

View →

Jul 9, 2025Jul 9 10:45 AMThomas Wozniewski
Proposed Sale
6,136$15.42$94.6K—

View →

Jul 9, 2025Jul 9 10:43 AMTeresa Marie Bitetti
Proposed Sale
52,649$15.42$811.8K—

View →

Jul 9, 2025Jul 9 10:41 AMRamona A Sequeira
Proposed Sale
102,972$15.42$1.6M—

View →

Jul 9, 2025Jul 9 10:38 AMMarcello Pignagnoli Agosti
Proposed Sale
18,622$15.42$287.2K—

View →

Jul 9, 2025Jul 9 10:36 AMLauren Rusckowski Duprey
Proposed Sale
40,919$15.42$631.0K—

View →

Jul 9, 2025Jul 9 10:34 AMJulie Kim
Proposed Sale
58,559$15.42$903.0K—

View →

Jul 9, 2025Jul 9 10:32 AMGiles Richard Platford
Proposed Sale
28,552$15.42$440.3K—

View →

Jul 9, 2025Jul 9 10:29 AMGabriele Ricci
Proposed Sale
26,874$15.42$414.4K—

View →

Jul 9, 2025Jul 9 10:26 AMElaine Mary Shannon
Proposed Sale
4,477$15.42$69.0K—

View →

Jul 9, 2025Jul 9 10:23 AMChristophe Pierre Weber
Proposed Sale
34,857$15.42$537.5K—

View →

Jul 9, 2025Jul 9 10:20 AMAndrew Plump
Proposed Sale
169,313$15.42$2.6M—

View →

Jul 9, 2025Jul 9 10:17 AMAkiko Amakawa
Proposed Sale
5,608$15.42$86.5K—

View →

Aug 23, 2024Aug 23 12:36 AMGiles Richard Platford
Proposed Sale
19,073$14.94$285.0K—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 10, 2026Jul 6 10:29 PMSteven GillisDirector
Disposition
1,152—0(D)

View →

Jul 1, 2026Jul 6 10:29 PMSteven GillisDirector
Grant/Award
1,319—1,319(D)

View →

Jul 10, 2026Jul 6 10:28 PMJohn MaraganoreDirector
Disposition
1,152—0(D)

View →

Jul 1, 2026Jul 6 10:28 PMJohn MaraganoreDirector
Grant/Award
1,319—1,319(D)

View →

Jul 10, 2026Jul 6 10:28 PMKimberly A. ReedDirector
Disposition
1,152—0(D)

View →

Jul 1, 2026Jul 6 10:28 PMKimberly A. ReedDirector
Grant/Award
1,319—1,319(D)

View →

Jul 10, 2026Jul 6 10:14 PMMasami IijimaDirector
Disposition
2,152—0(D)

View →

Jul 1, 2026Jul 6 10:14 PMMasami IijimaDirector
Grant/Award
1,937—1,937(D)

View →

Jul 1, 2026Jul 6 10:12 PMBruce D BroussardDirector
Grant/Award
1,319—1,319(D)

View →

Jul 1, 2026Jul 6 10:11 PMPaulus StoffelsDirector
Grant/Award
1,307—1,307(D)

View →

Jul 1, 2026Jul 6 10:10 PMKoichiro KimuraDirector
Grant/Award
1,937—1,937(D)

View →

Jul 10, 2026Jul 6 10:10 PMMiki TsusakaDirector
Disposition
2,152—0(D)

View →

Jul 1, 2026Jul 6 10:10 PMMiki TsusakaDirector
Grant/Award
1,937—1,937(D)

View →

Jul 10, 2026Jul 6 10:09 PMAsuka MiyabashiraPresident, Japan Pharma B.U.
Disposition
1,022—0(D)

View →

Jul 1, 2026Jul 6 10:09 PMAsuka MiyabashiraPresident, Japan Pharma B.U.
Grant/Award
1,994—666(D)

View →

Jul 10, 2026Jul 6 10:09 PMMilano FurutaDirector, Chief Financial Officer
Disposition
16,619—0(D)

View →

Jul 1, 2026Jul 6 10:09 PMMilano FurutaDirector, Chief Financial Officer
Grant/Award
12,864—4,288(D)

View →

Jul 1, 2026Jul 6 10:02 PMJulie So-Young KimDirector, President and CEO
Grant/Award
23,225—7,743(D)

View →

Apr 27, 2026Apr 28 10:08 AMChristophe Pierre WeberDirector, President and CEO
Grant/Award
78,978—125,345(D)

View →

Apr 27, 2026Apr 28 10:08 AMMilano FurutaDirector, Chief Financial Officer
Grant/Award
7,814—16,619(D)

View →